Article Details

Glofitamab by F. Hoffmann-La Roche for Chronic Lymphocytic Leukemia (CLL)

Retrieved on: 2024-06-18 22:50:20

Tags for this article:

Click the tags to see associated articles and topics

Glofitamab by F. Hoffmann-La Roche for Chronic Lymphocytic Leukemia (CLL). View article details on hiswai:

Excerpt

Glofitamab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Chronic Lymphocytic Leukemia (CLL).

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up